Screening multi‐dimensional heterogeneous populations for infectious diseases under scarce testing resources, with application to COVID‐19
Testing provides essential information for managing infectious disease outbreaks, such as the COVID‐19 pandemic. When testing resources are scarce, an important managerial decision is who to test. This decision is compounded by the fact that potential testing subjects are heterogeneous in multiple d...
Saved in:
| Published in: | Naval research logistics Vol. 69; no. 1; pp. 3 - 20 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Hoboken, USA
John Wiley & Sons, Inc
01.02.2022
Wiley Subscription Services, Inc |
| Subjects: | |
| ISSN: | 0894-069X, 1520-6750, 1520-6750 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Testing provides essential information for managing infectious disease outbreaks, such as the COVID‐19 pandemic. When testing resources are scarce, an important managerial decision is who to test. This decision is compounded by the fact that potential testing subjects are heterogeneous in multiple dimensions that are important to consider, including their likelihood of being disease‐positive, and how much potential harm would be averted through testing and the subsequent interventions. To increase testing coverage, pooled testing can be utilized, but this comes at a cost of increased false‐negatives when the test is imperfect. Then, the decision problem is to partition the heterogeneous testing population into three mutually exclusive sets: those to be individually tested, those to be pool tested, and those not to be tested. Additionally, the subjects to be pool tested must be further partitioned into testing pools, potentially containing different numbers of subjects. The objectives include the minimization of harm (through detection and mitigation) or maximization of testing coverage. We develop data‐driven optimization models and algorithms to design pooled testing strategies, and show, via a COVID‐19 contact tracing case study, that the proposed testing strategies can substantially outperform the current practice used for COVID‐19 contact tracing (individually testing those contacts with symptoms). Our results demonstrate the substantial benefits of optimizing the testing design, while considering the multiple dimensions of population heterogeneity and the limited testing capacity. |
|---|---|
| Bibliography: | Funding information National Science Foundation, Division of Civil, Mechanical and Manufacturing Innovation, 1761842 History Accepted by Sanjay Mehrotra, healthcare management ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 HistoryAccepted by Sanjay Mehrotra, healthcare management Funding information National Science Foundation, Division of Civil, Mechanical and Manufacturing Innovation, 1761842 |
| ISSN: | 0894-069X 1520-6750 1520-6750 |
| DOI: | 10.1002/nav.21985 |